Brain tumors are malignant tumors residing in the brain. They can be removed via surgery (for primary treatment), or with the combination of chemotherapy or radiotherapy. Patients are given anti-seizure drugs or pain killers to alleviate the symptoms of chemotherapy.
The demand for brain cancer treatment drugs has nearly doubled due to the geriatric populace and the prevalence of cancer. This trend is expected to continue over the forecast period (2018-2023). The Chinese government has introduced initiatives encouraging the growth of this industry. It expects large and small players to cooperate with each other in an effort to regulate the industry.
Download Full Research Report of Brain Cancer Treatment Drugs Market @ http://www.radiantinsights.com/research/brain-cancer-treatment-drugs-markets-in-china
Although China has progressed in R&D to manufacture new drugs, it suffers from innovation and lack of skilled professionals to produce branded drugs. This could inhibit the regional growth of the market in the coming years.
Products classified as drugs to treat brain cancer are steroids, anti-tumor antibiotics, mitotic inhibitors, antimetabolites, alkylating agents, and hormones. Drugs considered as safe to use are temozolomide, lomustine, everolimus, bevacizumab, and afinitor, to name a few. Temozolomide is an alkylating agent given to patients after chemotherapy. It reportedly has the ability to kill cancer cells.
Request a Free Sample Copy of this Report @ http://www.radiantinsights.com/research/brain-cancer-treatment-drugs-markets-in-china/request-sample
Glioblastoma multiforme (GBM) is an aggressive form of brain cancer which responds to treatment of temozolomide. A major factor eluding the success of these drugs is the blood-brain barrier. The blood-brain barrier only allows the entry of necessary nutrients and flushes out toxic elements. To overcome this situation, antitumor drugs are attached with a lipophilic agent. Propentofylline (or PPF) is a new drug which can limit the growth of GBM.
Well-known vendors in the market are Shanghai Abbott Pharmaceutical Co., Ltd., Roche (Shanghai) Pharmaceutical Co., Ltd., and Jiangsu Hansen Pharmaceutical Co., Ltd. The current market players are focusing their research on oncology and their various treatments. The market has high expectation of the government’s healthcare budget which can cover almost 90% of the country’s population. But the market is open to investment from foreign companies.
Read more related reports by Radiant Insights:
- Respiratory Drugs Market- http://www.radiantinsights.com/research/respiratory-drugs-markets-in-china
China’s demand for Respiratory Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China’s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
- Anesthetic Drugs Market- http://www.radiantinsights.com/research/anesthetic-drugs-markets-in-china
China’s demand for Anesthetic Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China’s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
About Radiant Insights, Inc
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.
Corporate Sales Specialist, USA
Radiant Insights, Inc
Toll Free: 1-888-202-9519